You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STI571 (Gleevec)

Showing 251 - 265 of 265
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma Trial in Pavia (Imatinib mesylate plus Gemcitabine)

Unknown status
  • Mesothelioma
  • Imatinib mesylate plus Gemcitabine
  • Pavia, Italy
    Medical Oncology, IRCCS San Matteo University Hospital Foundatio
Oct 29, 2007

Chronic Myeloid Leukemia Trial in Bologna (Imatinib (STI571))

Completed
  • Chronic Myeloid Leukemia
  • Imatinib (STI571)
  • Bologna, Italy
    Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Un
Aug 9, 2007

Chronic Myeloid Leukemia Trial (STI571)

Completed
  • Chronic Myeloid Leukemia
  • (no location specified)
Aug 2, 2007

Chronic Myeloid Leukemia Trial (STI571 and PEG INTRON)

Terminated
  • Chronic Myeloid Leukemia
  • STI571 and PEG INTRON
  • (no location specified)
Aug 2, 2007

Gastric Adenocarcinoma Trial in Atlanta (Gleevec, Taxotere)

Terminated
  • Gastric Adenocarcinoma
  • Gleevec, Taxotere
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Dec 27, 2007

Chronic Myeloid Leukemia Trial in Bologna (STI571 (400 mg/day; or 800 mg/day))

Completed
  • Chronic Myeloid Leukemia
  • STI571 (400 mg/day; or 800 mg/day)
  • Bologna, Italy
    Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli"
Aug 9, 2007

Philadelphia Positive Acute Lymphoblastic Leukemia, Lymphoid Blastic Phase of Chronic Myeloid Leukemia Trial in Frankfurt/Main

Unknown status
  • Philadelphia Positive Acute Lymphoblastic Leukemia
  • Lymphoid Blastic Phase of Chronic Myeloid Leukemia
  • Frankfurt/Main, Germany
    Medizinische Klinik II, Johann Wolfgang Goethe Universität
Oct 18, 2007

Acute Lymphocytic Leukemia Trial in Lyon (imatinib)

Unknown status
  • Acute Lymphocytic Leukemia
  • Lyon, France
    Xavier THOMAS
Apr 26, 2007

Myeloid Leukemia, Chronic, Chronic-Phase Trial in Bologna (Imatinib Mesilate (Glivec))

Completed
  • Myeloid Leukemia, Chronic, Chronic-Phase
  • Imatinib Mesilate (Glivec)
  • Bologna, Italy
    Policlinico S.Orsola-Malpighi, Istituto di Ematologia e Oncologi
Aug 2, 2007

Chronic Myeloid Leukemia Trial in Lyon (Imatinib mesylate 600mg/day, Peg-Interféron at 90 microg/week)

Unknown status
  • Chronic Myeloid Leukemia
  • Imatinib mesylate 600mg/day
  • Peg-Interféron at 90 microg/week
  • Lyon, France
    Franck NICOLINI
Apr 26, 2007

Chronic Myeloid Leukemia Trial in Innsbruck (Imatinib)

Unknown status
  • Chronic Myeloid Leukemia
  • Innsbruck, Tyrol, Austria
    Medical University Innsbruck
Jun 16, 2006

Gastrointestinal Stromal Tumors Trial in Montreal (Imatinib mesylate)

Unknown status
  • Gastrointestinal Stromal Tumors
  • Imatinib mesylate
  • Montreal, Quebec, Canada
    Maisonneuve-Rosemont Hospital
Apr 6, 2006

Cancer Trial in Villejuif, Amsterdam, Birmingham (Glivec, Gleevec)

Terminated
  • Cancer
  • Villejuif, France
  • +2 more
Sep 7, 2006

Idiopathic Pulmonary Fibrosis, Lung Disease, Pulmonary Fibrosis Trial (Imatinib Mesylate (Gleevec))

Completed
  • Idiopathic Pulmonary Fibrosis
  • +2 more
  • Imatinib Mesylate (Gleevec)
  • (no location specified)
Oct 4, 2005

Leukemia,Myeloid, Chronic, Leukemia,Myeloid,Philadelphia-Positive Trial in Farmington (Heat Shock Protein 70 HSP70)

Completed
  • Leukemia,Myeloid, Chronic
  • Leukemia,Myeloid,Philadelphia-Positive
  • Heat Shock Protein 70 HSP70
  • Farmington, Connecticut
    University of Connecticut Health Center
Jun 23, 2005